{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:47:54Z","timestamp":1793170074393,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.drup.2024.101181","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T01:06:24Z","timestamp":1733274384000},"page":"101181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["5-methylcytosine methylation of MALAT1 promotes resistance to sorafenib in hepatocellular carcinoma through ELAVL1\/SLC7A11-mediated ferroptosis"],"prefix":"10.1016","volume":"78","author":[{"given":"Chuan-Jian","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Xiang","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-He","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Qiang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Zhen","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Qing","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-Lin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Fang","family":"Xian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Qiang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Fang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.drup.2024.101181_bib1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1021\/acschembio.8b00807","article-title":"Selective small-molecule targeting of a triple helix encoded by the long noncoding RNA, MALAT1","volume":"14","author":"Abulwerdi","year":"2019","journal-title":"ACS Chem. Biol."},{"issue":"1","key":"10.1016\/j.drup.2024.101181_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13045-018-0606-4","article-title":"MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches","volume":"11","author":"Amodio","year":"2018","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.drup.2024.101181_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13059-016-1139-1","article-title":"Distinct 5-methylcytosine profiles in poly(A) RNA from mouse embryonic stem cells and brain","volume":"18","author":"Amort","year":"2017","journal-title":"Genome Biol."},{"issue":"3","key":"10.1016\/j.drup.2024.101181_bib4","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA: A Cancer J. Clin."},{"key":"10.1016\/j.drup.2024.101181_bib5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.canlet.2021.04.020","article-title":"METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-\u03baB to promote the malignant progression of IDH-wildtype glioma","volume":"511","author":"Chang","year":"2021","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.drup.2024.101181_bib6","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12943-024-02089-6","article-title":"Writers, readers, and erasers RNA modifications and drug resistance in cancer","volume":"23","author":"Chen","year":"2024","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.drup.2024.101181_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1639","article-title":"Dynamic transcriptomic m(5) C and its regulatory role in RNA processing","volume":"12","author":"Chen","year":"2021","journal-title":"Wiley Interdiscip. Rev. RNA"},{"issue":"1","key":"10.1016\/j.drup.2024.101181_bib8","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1038\/s41467-020-16722-7","article-title":"m(5)C modification of mRNA serves a DNA damage code to promote homologous recombination","volume":"11","author":"Chen","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.drup.2024.101181_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.drup.2024.101181_bib10","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41392-022-01175-9","article-title":"RNA modifications: importance in immune cell biology and related diseases","volume":"7","author":"Cui","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"3","key":"10.1016\/j.drup.2024.101181_bib11","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1105\/tpc.16.00751","article-title":"Transcriptome-wide mapping of RNA 5-methylcytosine in Arabidopsis mRNAs and noncoding RNAs","volume":"29","author":"David","year":"2017","journal-title":"Plant Cell"},{"issue":"5","key":"10.1016\/j.drup.2024.101181_bib12","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.drup.2024.101181_bib13","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.02523","article-title":"Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis","volume":"3","author":"Dixon","year":"2014","journal-title":"eLife"},{"issue":"5","key":"10.1016\/j.drup.2024.101181_bib14","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1158\/1535-7163.MCT-19-0203","article-title":"Long noncoding RNA MALAT1 contributes to Sorafenib resistance by targeting miR-140-5p\/Aurora-A signaling in hepatocellular carcinoma","volume":"19","author":"Fan","year":"2020","journal-title":"Mol. Cancer Ther."},{"issue":"8","key":"10.1016\/j.drup.2024.101181_bib15","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/s41419-023-06049-8","article-title":"m5C-methylated lncRNA NR_033928 promotes gastric cancer proliferation by stabilizing GLS mRNA to promote glutamine metabolism reprogramming","volume":"14","author":"Fang","year":"2023","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.drup.2024.101181_bib16","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00018-024-05292-2","article-title":"Poly (ADP-ribose) polymerase 1 promotes HuR\/ELAVL1 cytoplasmic localization and inflammatory gene expression by regulating p38 MAPK activity","volume":"81","author":"Fu","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"issue":"12","key":"10.1016\/j.drup.2024.101181_bib17","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114351","article-title":"YAP\/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis","volume":"13","author":"Gao","year":"2021","journal-title":"EMBO Mol. Med."},{"issue":"22","key":"10.1016\/j.drup.2024.101181_bib18","doi-asserted-by":"crossref","first-page":"22240","DOI":"10.1021\/acsnano.3c01199","article-title":"Long noncoding RNA URB1-Antisense RNA 1 (AS1) suppresses Sorafenib-induced ferroptosis in hepatocellular carcinoma by driving ferritin phase separation","volume":"17","author":"Gao","year":"2023","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.drup.2024.101181_bib19","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41420-022-01218-8","article-title":"Role of ferroptosis on tumor progression and immunotherapy","volume":"8","author":"Gong","year":"2022","journal-title":"Cell Death Discov."},{"issue":"12","key":"10.1016\/j.drup.2024.101181_bib20","first-page":"15903","article-title":"MALAT1 is an oncogenic long non-coding RNA associated with tumor invasion in non-small cell lung cancer regulated by DNA methylation","volume":"8","author":"Guo","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.drup.2024.101181_bib21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.semcancer.2020.11.007","article-title":"RNA methylations in human cancers","volume":"75","author":"Han","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.drup.2024.101181_bib22","article-title":"Dual specific phosphatase 4 suppresses ferroptosis and enhances sorafenib resistance in hepatocellular carcinoma","volume":"73","author":"Hao","year":"2024","journal-title":"Drug Resist. Update. Rev. Comment. Antimicrob. Anticancer Chemother."},{"issue":"1","key":"10.1016\/j.drup.2024.101181_bib23","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13062-024-00477-y","article-title":"NSUN2 relies on ALYREF to regulate Nrf2-mediated oxidative stress and alleviate Dox-induced liver injury","volume":"19","author":"Huang","year":"2024","journal-title":"Biol. Direct"},{"issue":"1","key":"10.1016\/j.drup.2024.101181_bib24","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41392-020-00264-x","article-title":"Targeted therapy for hepatocellular carcinoma","volume":"5","author":"Huang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"39","key":"10.1016\/j.drup.2024.101181_bib25","doi-asserted-by":"crossref","first-page":"8031","DOI":"10.1038\/sj.onc.1206928","article-title":"MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer","volume":"22","author":"Ji","year":"2003","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.drup.2024.101181_bib26","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.drup.2024.101181_bib27","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/med.21933","article-title":"Ferroptosis-modulating small molecules for targeting drug-resistant cancer: challenges and opportunities in manipulating redox signaling","volume":"43","author":"Koeberle","year":"2023","journal-title":"Med. Res. Rev."},{"issue":"8","key":"10.1016\/j.drup.2024.101181_bib28","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","article-title":"Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy","volume":"12","author":"Koppula","year":"2021","journal-title":"Protein Cell"},{"issue":"4","key":"10.1016\/j.drup.2024.101181_bib29","first-page":"926","article-title":"Mechanisms of drug resistance in HCC","volume":"79","author":"Ladd","year":"2024","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.drup.2024.101181_bib30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13046-024-03061-4","article-title":"PLAG1 interacts with GPX4 to conquer vulnerability to sorafenib induced ferroptosis through a PVT1\/miR-195-5p axis-dependent manner in hepatocellular carcinoma","volume":"43","author":"Li","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.drup.2024.101181_bib31","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41420-022-00975-w","article-title":"Silencing of lncRNA MALAT1 facilitates erastin-induced ferroptosis in endometriosis through miR-145-5p\/MUC1 signaling","volume":"8","author":"Liang","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.drup.2024.101181_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102312","article-title":"Hypoxia-induced HIF-1\u03b1\/lncRNA-PMAN inhibits ferroptosis by promoting the cytoplasmic translocation of ELAVL1 in peritoneal dissemination from gastric cancer","volume":"52","author":"Lin","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.drup.2024.101181_bib33","article-title":"Upregulation of CoQ shifts ferroptosis dependence from GPX4 to FSP1 in acquired radioresistance","volume":"73","author":"Lin","year":"2024","journal-title":"Drug Resist. Update.\u00a0Rev. Comment. Antimicrob. Anticancer Chemother."},{"issue":"7","key":"10.1016\/j.drup.2024.101181_bib34","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/ijc.28159","article-title":"Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib","volume":"133","author":"Louandre","year":"2013","journal-title":"Int. J. Cancer"},{"issue":"8","key":"10.1016\/j.drup.2024.101181_bib35","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1038\/s41418-023-01188-z","article-title":"Targeting N-glycosylation of 4F2hc mediated by glycosyltransferase B3GNT3 sensitizes ferroptosis of pancreatic ductal adenocarcinoma","volume":"30","author":"Ma","year":"2023","journal-title":"Cell Death Differ."},{"issue":"5","key":"10.1016\/j.drup.2024.101181_bib36","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1158\/0008-5472.CAN-16-1508","article-title":"Long noncoding RNA MALAT1 promotes hepatocellular carcinoma development by SRSF1 upregulation and mTOR activation","volume":"77","author":"Malakar","year":"2017","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.drup.2024.101181_bib37","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12943-020-01263-w","article-title":"The role of m(6)A, m(5)C and \u03a8 RNA modifications in cancer: novel therapeutic opportunities","volume":"20","author":"Nombela","year":"2021","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.drup.2024.101181_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109178","article-title":"ELAVL1 primarily couples mRNA stability with the 3\u2032 UTRs of interferon-stimulated genes","volume":"35","author":"Rothamel","year":"2021","journal-title":"Cell Rep."},{"issue":"13","key":"10.1016\/j.drup.2024.101181_bib39","doi-asserted-by":"crossref","DOI":"10.1172\/JCI180071","article-title":"Epigenetic developmental mechanisms underlying sex differences in cancer","volume":"134","author":"Rubin","year":"2024","journal-title":"J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.drup.2024.101181_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1581","article-title":"Understanding and targeting the disease-related RNA binding protein human antigen R (HuR)","volume":"11","author":"Schultz","year":"2020","journal-title":"Wiley Interdiscip. Rev. RNA"},{"issue":"1","key":"10.1016\/j.drup.2024.101181_bib41","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12943-020-01194-6","article-title":"Novel insight into the regulatory roles of diverse RNA modifications: re-defining the bridge between transcription and translation","volume":"19","author":"Shi","year":"2020","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.drup.2024.101181_bib42","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1074\/jbc.M115.697821","article-title":"Interleukin 1\u03b2 regulation of the system xc- substrate-specific subunit, xCT, in primary mouse astrocytes involves the RNA-binding protein HuR","volume":"291","author":"Shi","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.drup.2024.101181_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1300","article-title":"Loss of LncRNA DUXAP8 synergistically enhanced sorafenib induced ferroptosis in hepatocellular carcinoma via SLC7A11 de-palmitoylation","volume":"13","author":"Shi","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.drup.2024.101181_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15074","article-title":"The glutamate\/cystine xCT antiporter antagonizes glutamine metabolism and reduces nutrient flexibility","volume":"8","author":"Shin","year":"2017","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.drup.2024.101181_bib45","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41420-021-00756-x","article-title":"The METTL3\/MALAT1\/PTBP1\/USP8\/TAK1 axis promotes pyroptosis and M1 polarization of macrophages and contributes to liver fibrosis","volume":"7","author":"Shu","year":"2021","journal-title":"Cell Death Discov."},{"issue":"45","key":"10.1016\/j.drup.2024.101181_bib46","doi-asserted-by":"crossref","first-page":"6906","DOI":"10.1038\/s41388-020-01475-w","article-title":"Aberrant NSUN2-mediated m(5)C modification of H19 lncRNA is associated with poor differentiation of hepatocellular carcinoma","volume":"39","author":"Sun","year":"2020","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.drup.2024.101181_bib47","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41392-020-0187-x","article-title":"The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects","volume":"5","author":"Tang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"5","key":"10.1016\/j.drup.2024.101181_bib48","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41419-021-03718-4","article-title":"GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2\/GPX4 axis","volume":"12","author":"Wang","year":"2021","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.drup.2024.101181_bib49","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41419-023-05661-y","article-title":"m(5)C-dependent cross-regulation between nuclear reader ALYREF and writer NSUN2 promotes urothelial bladder cancer malignancy through facilitating RABL6\/TK1 mRNAs splicing and stabilization","volume":"14","author":"Wang","year":"2023","journal-title":"Cell Death Dis."},{"issue":"11","key":"10.1016\/j.drup.2024.101181_bib50","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/s41419-023-06311-z","article-title":"LINC01133 can induce acquired ferroptosis resistance by enhancing the FSP1 mRNA stability through forming the LINC01133-FUS-FSP1 complex","volume":"14","author":"Wang","year":"2023","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.drup.2024.101181_bib51","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ymthe.2020.09.024","article-title":"A nuclear long non-coding RNA LINC00618 accelerates ferroptosis in a manner dependent upon Apoptosis","volume":"29","author":"Wang","year":"2021","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"issue":"23","key":"10.1016\/j.drup.2024.101181_bib52","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1021\/acs.accounts.3c00448","article-title":"Emerging roles of RNA methylation in development","volume":"56","author":"Wang","year":"2023","journal-title":"Acc. Chem. Res."},{"issue":"11","key":"10.1016\/j.drup.2024.101181_bib53","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1038\/s41418-019-0304-y","article-title":"Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA","volume":"26","author":"Wang","year":"2019","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.drup.2024.101181_bib54","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12943-023-01780-4","article-title":"Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2\/YBX1\/QSOX1 axis in EGFR-mutant non-small-cell lung cancer","volume":"22","author":"Wang","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2024.101181_bib55","article-title":"Overcoming cancer chemotherapy resistance by the induction of ferroptosis","volume":"66","author":"Wang","year":"2023","journal-title":"Drug Resist. Update. Rev. Comment. Antimicrob. Anticancer Chemother."},{"issue":"1","key":"10.1016\/j.drup.2024.101181_bib56","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1186\/s12967-024-05287-4","article-title":"NSUN2 affects diabetic retinopathy progression by regulating MUC1 expression through RNA m(5)C methylation.","volume":"22","author":"Wang","year":"2024","journal-title":"J. Transl. Med."},{"issue":"7","key":"10.1016\/j.drup.2024.101181_bib57","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/cac2.12158","article-title":"The role of the HIF-1\u03b1\/ALYREF\/PKM2 axis in glycolysis and tumorigenesis of bladder cancer","volume":"41","author":"Wang","year":"2021","journal-title":"Cancer Commun."},{"issue":"1","key":"10.1016\/j.drup.2024.101181_bib58","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1186\/s13046-019-1439-x","article-title":"JMJD2C promotes colorectal cancer metastasis via regulating histone methylation of MALAT1 promoter and enhancing \u03b2-catenin signaling pathway","volume":"38","author":"Wu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.drup.2024.101181_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114179","article-title":"The RNA-binding protein HuR in human cancer: a friend or foe?","volume":"184","author":"Wu","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.drup.2024.101181_bib60","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1053\/j.gastro.2019.05.010","article-title":"RNA-binding protein HuR regulates paneth cell function by altering membrane localization of TLR2 via post-transcriptional control of CNPY3","volume":"157","author":"Xiao","year":"2019","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.drup.2024.101181_bib61","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/cr.2017.55","article-title":"5-methylcytosine promotes mRNA export - NSUN2 as the methyltransferase and ALYREF as an m(5)C reader","volume":"27","author":"Yang","year":"2017","journal-title":"Cell Res."},{"issue":"2","key":"10.1016\/j.drup.2024.101181_bib62","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ccell.2024.01.007","article-title":"Precision treatment in advanced hepatocellular carcinoma","volume":"42","author":"Yang","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2024.101181_bib63","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cca.2021.01.001","article-title":"The epitranscriptome of long noncoding RNAs in metabolic diseases","volume":"515","author":"Yin","year":"2021","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"issue":"8","key":"10.1016\/j.drup.2024.101181_bib64","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41419-022-05173-1","article-title":"LncRNA HEPFAL accelerates ferroptosis in hepatocellular carcinoma by regulating SLC7A11 ubiquitination","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.drup.2024.101181_bib65","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","article-title":"Ferroptosis in cancer therapy: a novel approach to reversing drug resistance","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.drup.2024.101181_bib66","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41392-024-01848-7","article-title":"Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.drup.2024.101181_bib67","article-title":"Potential targets and therapeutics for cancer stem cell-based therapy against drug resistance in hepatocellular carcinoma","volume":"74","author":"Zhao","year":"2024","journal-title":"Drug Resist. Update. Rev. Comment. Antimicrob. Anticancer Chemother."},{"issue":"1","key":"10.1016\/j.drup.2024.101181_bib68","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/s12935-021-02113-5","article-title":"The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1\/miR-26b\/HMGA2 axis","volume":"21","author":"Zhao","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"5","key":"10.1016\/j.drup.2024.101181_bib69","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1273","article-title":"NSUN2-mediated m(5) C RNA methylation dictates retinoblastoma progression through promoting PFAS mRNA stability and expression","volume":"13","author":"Zuo","year":"2023","journal-title":"Clin. Transl. Med."}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764624001390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764624001390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T14:48:31Z","timestamp":1734187711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764624001390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":69,"alternative-id":["S1368764624001390"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2024.101181","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"5-methylcytosine methylation of MALAT1 promotes resistance to sorafenib in hepatocellular carcinoma through ELAVL1\/SLC7A11-mediated ferroptosis","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2024.101181","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101181"}}